190 related articles for article (PubMed ID: 38139284)
1. Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple Sclerosis.
Kwakowsky A; Chawdhary B; de Souza A; Meyer E; Kaye AH; Green CR; Stylli SS; Danesh-Meyer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139284
[TBL] [Abstract][Full Text] [Related]
2. Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury.
Roger E; Chadjichristos CE; Kavvadas P; Price GW; Cliff CL; Hadjadj S; Renciot J; Squires PE; Hills CE
Cell Commun Signal; 2023 Sep; 21(1):263. PubMed ID: 37770948
[TBL] [Abstract][Full Text] [Related]
3. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
Front Immunol; 2018; 9():2588. PubMed ID: 30464764
[TBL] [Abstract][Full Text] [Related]
4. Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
Mugisho OO; Aryal J; Shome A; Lyon H; Acosta ML; Green CR; Rupenthal ID
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835288
[TBL] [Abstract][Full Text] [Related]
5. Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model.
Takase EO; Yamasaki R; Nagata S; Watanabe M; Masaki K; Yamaguchi H; Kira JI; Takeuchi H; Isobe N
Sci Rep; 2024 May; 14(1):10877. PubMed ID: 38740862
[TBL] [Abstract][Full Text] [Related]
6. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease.
Mugisho OO; Rupenthal ID; Paquet-Durand F; Acosta ML; Green CR
Expert Opin Ther Targets; 2019 Oct; 23(10):855-863. PubMed ID: 31554417
[No Abstract] [Full Text] [Related]
7. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the NLRP3 Inflammasome with MCC950 Alleviates Neurological Impairment in the Brain of EAE Mice.
Hou B; Yin J; Liu S; Guo J; Zhang B; Zhang Z; Yang L; Tan X; Long Y; Feng S; Zhou J; Wu Y; Wang X; Han S; Wang Z; He X
Mol Neurobiol; 2024 Mar; 61(3):1318-1330. PubMed ID: 37702910
[TBL] [Abstract][Full Text] [Related]
9. Brain gray matter astroglia-specific connexin 43 ablation attenuates spinal cord inflammatory demyelination.
Une H; Yamasaki R; Nagata S; Yamaguchi H; Nakamuta Y; Indiasari UC; Cui Y; Shinoda K; Masaki K; Götz M; Kira JI
J Neuroinflammation; 2021 Jun; 18(1):126. PubMed ID: 34090477
[TBL] [Abstract][Full Text] [Related]
10. Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.
Lyon H; Shome A; Rupenthal ID; Green CR; Mugisho OO
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396676
[TBL] [Abstract][Full Text] [Related]
11. Potential role of BAY11-7082, a NF-κB blocker inhibiting experimental autoimmune encephalomyelitis in C57BL/6J mice via declining NLRP3 inflammasomes.
Lang Y; Chu F; Liu L; Zheng C; Li C; Shen D; Liu S; Zhang W; Cui L; Zhu J
Clin Exp Immunol; 2022 May; 207(3):378-386. PubMed ID: 35553640
[TBL] [Abstract][Full Text] [Related]
12. A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis.
Contarini G; Franceschini D; Facci L; Barbierato M; Giusti P; Zusso M
J Neuroinflammation; 2019 Jun; 16(1):126. PubMed ID: 31221190
[TBL] [Abstract][Full Text] [Related]
13. Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease.
Mat Nor MN; Rupenthal ID; Green CR; Acosta ML
Neurotherapeutics; 2020 Jan; 17(1):371-387. PubMed ID: 31637594
[TBL] [Abstract][Full Text] [Related]
14. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
Front Immunol; 2020; 11():571844. PubMed ID: 33193354
[TBL] [Abstract][Full Text] [Related]
15. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Barclay W; Shinohara ML
Brain Pathol; 2017 Mar; 27(2):213-219. PubMed ID: 27997058
[TBL] [Abstract][Full Text] [Related]
16. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model.
Sharma S; Risen S; Gilberto VS; Boland S; Chatterjee A; Moreno JA; Nagpal P
ACS Chem Neurosci; 2024 Apr; 15(7):1596-1608. PubMed ID: 38526238
[TBL] [Abstract][Full Text] [Related]
17. Blocking connexin 43 hemichannel-mediated ATP release reduces communication within and between tubular epithelial cells and medullary fibroblasts in a model of diabetic nephropathy.
Williams BM; Cliff CL; Demirel I; Squires PE; Hills CE
Diabet Med; 2022 Dec; 39(12):e14963. PubMed ID: 36256487
[TBL] [Abstract][Full Text] [Related]
18. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
[TBL] [Abstract][Full Text] [Related]
20. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis.
Desu HL; Plastini M; Illiano P; Bramlett HM; Dietrich WD; de Rivero Vaccari JP; Brambilla R; Keane RW
J Neuroinflammation; 2020 May; 17(1):143. PubMed ID: 32366256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
